NCT00326885 2018-10-17Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant AscitesNeovii BiotechPhase 2 Completed32 enrolled 12 charts
NCT00005906 2010-04-30Treatment With Octreotide in Patients With LymphangioleiomyomatosisNational Institutes of Health Clinical Center (CC)Phase 2 Completed4 enrolled 8 charts